Navigation Links
Securus Medical Group Raises $6.5M, Appoints New CEO
Date:10/29/2013

CLEVELAND, Oct. 29, 2013 /PRNewswire-USNewswire/ -- Securus Medical Group, Inc., a privately held medical device company, announced the initial closing of a $6.5 million Series B financing led by new investor 3X5 Special Opportunity Fund, and that Steven Girouard, PhD has been named President and Chief Executive Officer.  A medical device industry veteran, Steve has held executive leadership roles at Johnson & Johnson, Guidant Corporation, Cleveland Clinic and Oakwood Medical Investors.  Existing investor RiverVest Venture Partners, as well as the University of Michigan Investment in New Technology Startups (MINTS) program, also participated in the financing.  Securus plans to use Series B proceeds to further develop their Aurora™ thermographic mapping system, a proprietary thermal measurement device that is expected to have several clinical applications for temperature monitoring during energy-based surgical procedures.  As part of the financing, Nicholas Walrod, Principal of 3X5 Special Opportunity Fund, will join the Board of Directors. 

(Photo: http://photos.prnewswire.com/prnh/20131029/DC05765)  

"We are enthusiastic in our support of Securus and we were delighted to attract Steve to lead the Company during this critical phase of development," said Walrod.  "We see an opportunity for several large medical device markets to benefit from Securus monitoring technology and Steve brings to Securus deep industry insights and a strong network in target markets for the Company." 

Securus plans to maintain its headquarters in Ohio on the campus of Cleveland Clinic's Global Cardiovascular Innovation Center, an early grant-based supporter of the Company.  The Company's 2011 Series A financing was led by RiverVest and included JumpStart and the University of Michigan.

3x5 Special Opportunity Fund, L.P. is a St. Louis and Portland-based, closed-end private investment fund focused primarily on direct investments in later-stage companies within the healthcare and clean-tech sectors. The fund closed in early 2013 at approximately $80 million in committed capital, which it expects to deploy over six portfolio investments.

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit. For more information, please visit www.rivervest.com.


'/>"/>
SOURCE Securus Medical Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical Appoints Richard J. Eagle Vice President of Sales
2. Solta Medical to Report Third Quarter 2013 Results and Host Conference Call on November 11, 2013
3. Utah Hospital Saves Money and the Environment by Treating Its Own Medical Waste on Site
4. Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research
5. Epiditi - "COOL THE JEWELS!" The Only Form-Fitting Scrotal Ice Pack on the Planet - Now A Medical Crowdfunding Project
6. Middle Peak Medical Raises an Additional $3M to Develop Novel Mitral Valve Technology
7. Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
8. Media Sourcerys Secure Mobile Workflow App Deployed by CCS Medical to Expedite Product Delivery to Patients
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013
10. Varian Medical Systems Schedules Fiscal Year End Review for Investors in New York
11. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):